Table 4.

Results of subgroup analysis.

Characteristic		HOMA-IR			HbA1c
	Studies	Effect size (90% CI)	P Value	Studies	Effect size (90% CI)	P Value
	n				%
Participants			>0.2			>0.2
Non-T2D	13	−0.23 (−0.42, −0.04)		/	/
T2D	3	−0.59 (−1.48, 0.31)		5	−0.51 (−0.84, −0.18)
Period			>0.2			>0.2
<-12 weeks	6	−0.17 (−0.44, 0.11)		3	−0.49 (−0.84, −0.14)
>12 weeks	8	−0.32 (−0.57, −0.06)		2	0.26 (−0.56, 1.07)
Intensity			>0.2			>0.2
Low	2	−0.30 (−0.96, 0.35)		/	/
Moderate	5	−0.20 (−0.43, 0.02)		2	−0.51 (−0.90, −0.12)
High	6	−0.43 (−0.85, −0.22)		3	−0.09 (−0.65, 0.47)
Frequency			>0.2			>0.2
2 d per week	2	−0.45 (−1.06, 0.17)		/	/
3 d per week	9	−0.28 (−0.64,0.09)		5	−0.37 (−0.69, −0.05)
4 d per week	3	−0.21 (−0.44, 0.02)		/	/
Progression			>0.2			>0.2
Yes	4	−0.42 (−0.88, 0.03)		5	−0.37 (−0.69, −0.05)
No	10	−0.21 (−0.42, −0.01)		/	/
Sets			>0.2			>0.2
3 times	6	−0.25 (−0.64, 0.13)		5	−0.37 (−0.69, −0.05)
4 times	5	−0.45 (−0.99,0.99)		/	/